study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
MH-OMEGA-DEP_01,2011,randomized controlled trial,SMD,-0.3432,-0.5038,-0.1825,56,48,low,10.1038/s41398-019-0515-5,mental_health_journal,major_depression,Adults with major depression concerns,None reported,9
MH-OMEGA-DEP_02,2012,randomized controlled trial,SMD,-0.3720,-0.5286,-0.2154,60,51,some concerns,10.1016/j.plefa.2023.102572,mental_health_journal,major_depression,Adults with major depression concerns,Mild GI discomfort,10
MH-OMEGA-DEP_03,2013,randomized controlled trial,SMD,-0.4429,-0.5900,-0.2957,64,54,mixed,10.1212/WNL.0b013e3181a39691,mental_health_journal,major_depression,Adults with major depression concerns,Transient headache,11
